Ionis Pharmaceuticals(IONS) - 2023 Q3 - Earnings Call Presentation
Ionis Pharmaceuticals(IONS)2023-11-02 21:05On Today's Earnings Call Q3:23 Business Update and Financial Results 2 Brett Monia, Ph.D. Chief Executive Officer Beth Hougen Chief Financial Officer Eugene Schneider, M.D. Chief Clinical Development Officer Eric Swayze, Ph.D. Executive Vice President, Research IONIS Forward-Looking Statements 3 This presentation includes forward-looking statements regarding our business, financial guidance and the therapeutic and commercial potential of QALSODYTM (tofersen), SPINRAZA® (nusinersen), TEGSEDI® (inotersen), WA ...